Pune, India, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Prefilled syringes (PFS) are the most recent aids for administering injectable medicines. Both pharmaceutical and biotech companies deliver products ...

The prefilled syringe is indicated for wet age-related macular degeneration, diabetic macular edema and retinal vein occlusion. The syringe will be available in the U.S. later this year.

Please provide your email address to receive an email when new articles are posted on . The European Medicines Agency approved the Vabysmo 6 mg prefilled syringe for three retinal conditions ...

Fresh off earning FDA approval for a prefilled syringe version of Vyvgart Hytrulo for at-home administration, argenx is building buzz with a new direct-to-consumer campaign. The “Treatment MY ...

FDA approved Vyvgart Hytrulo prefilled syringe for gMG and CIDP self-injection in 20–30 seconds. Human factor studies showed patients and caregivers safely administered the new formulation.

Roche announced that the European Medicines Agency has approved Vabysmo (faricimab) 6.0 mg single-dose prefilled syringe (PFS) for use in the treatment of neovascular or ‘wet’ age-related macular ...

The prefilled syringe reduces administration steps for patients using Cortrophin Gel, which remains available in 5 mL and 1 mL vials. The company noted that the new prefilled syringe reduces the ...

“We understand patients experience MG and CIDP in different ways, and our prefilled syringe is an important innovation that provides patients with more freedom and flexibility to self-administer ...

SAN DIEGO, April 10, 2025 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme) today announced that argenx has received U.S. Food and Drug Administration (FDA) approval of VYVGART ® ...